SKI Market

Indian Indices

Nifty

25,910.05 30.90
(0.12%)

Sensex

84,562.78 84.11
( 0.10%)

Bank Nifty

58,517.55 135.60
( 0.23%)

Nifty IT

36,301.25 -378.20
( -1.03%)

Global Indices

Nasdaq

47,468.90 -806.92
(-1.67%)

Dow Jones

6,758.27 -113.65
(-1.65%)

Hang Seng

50,333.56 -948.27
(-1.85%)

Nikkei 225

9,693.83 -113.85
(-1.16%)

Forex

USD-INR

88.59 -0.09
(-0.10%)

EUR-INR

102.60 0.08
(0.08%)

GBP-INR

116.32 -0.42
(-0.36%)

JPY-INR

0.57 0.00
(-0.52%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lupin Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500257

INE326A01037

596.0364852

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LUPIN

17.57

93768.71

EPS(TTM)

Face Value()

Div & Yield %

116.81

0.58

Back

hindustan hardy ltd

Dynavision consolidated net profit declines 9.09% in the September 2025 quarter

Nov 12,2025

Net profit of Dynavision declined 9.09% to Rs 0.90 crore in the quarter ended September 2025 as against Rs 0.99 crore during the previous quarter ended September 2024. Sales rose 3.64% to Rs 3.42 crore in the quarter ended September 2025 as against Rs 3.30 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	3.42	3.30	4
OPM %	59.65	69.39	-
PBDT	1.98	2.04	-3
PBT	1.41	1.49	-5
NP	0.90	0.99	-9

25,910.05 30.90 (0.12%)

84,562.78 84.11 ( 0.10%)

58,517.55 135.60 ( 0.23%)

36,301.25 -378.20 ( -1.03%)

47,468.90 -806.92 (-1.67%)

6,758.27 -113.65 (-1.65%)

50,333.56 -948.27 (-1.85%)

9,693.83 -113.85 (-1.16%)

88.59 -0.09 (-0.10%)

102.60 0.08 (0.08%)

116.32 -0.42 (-0.36%)

0.57 0.00 (-0.52%)